The study, published Feb. 13 in The Lancet Regional Health, analyzed 2,486 patients with laboratory-confirmed COVID-19 in 2021 or 2022. Of those patients, 564 had two doses of an mRNA vaccine and 385 had three doses.
Here are three findings:
- Patients with two or three doses had better outcomes, including decreased 30-day mortality, hospitalization and ICU admissions.
- Black patients had higher rates of hospitalization.
- Hispanic patients had higher rates of ICU admission.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
